Skip to content
Sunday, November 22, 2026Independent education · Evidence in contextOur standards
MedicalGenetics.Science for life. Knowledge for care.
HomeGenetics toolsSource watchEveryday geneticsClinical practiceFor researchersArticle libraryTrusted resources
Home2026

Year: 2026

Conceptual transferrin with two iron-binding sites, one occupied, beside a ferritin storage shell with iron markers. Occupancy and particle counts are illustrative, not a patient result or an atomic model.
Genetic conditions

Hereditary hemochromatosis: HFE variants, ferritin and iron overload

October 27, 2026 Medical Genetics editorial team Comments Off on Hereditary hemochromatosis: HFE variants, ferritin and iron overload
Understand C282Y, H63D, ferritin and transferrin saturation, with practical examples of HFE results, iron overload and when further assessment helps.

[…]

At protein position 12, glycine changes to cysteine. The precise substitution matters for treatment evidence.
Cancer Genetics

KRAS G12C explained: testing, treatment evidence and inherited risk

October 27, 2026 Medical Genetics editorial team Comments Off on KRAS G12C explained: testing, treatment evidence and inherited risk
Read a KRAS G12C result: exact variant, tumour versus plasma testing, treatment context and trial outcomes, with practical examples.

[…]

Copper-like markers within a schematic liver cell and reduced export toward bile represent impaired copper handling in Wilson disease. This is not a molecular structure or measured copper level.
Rare disease diagnosis

Wilson disease and ATP7B: making sense of copper and genetic tests

October 26, 2026 Medical Genetics editorial team Comments Off on Wilson disease and ATP7B: making sense of copper and genetic tests
Read Wilson disease tests together: blood and urine copper, ceruloplasmin, ATP7B variants and family assessment, with practical examples.

[…]

A known familial marker is compared in two separate reports, illustrating targeted cascade testing.
Genetic counselling

Cascade testing: turn a familial variant into a clear testing question

October 25, 2026 Medical Genetics editorial team Comments Off on Cascade testing: turn a familial variant into a clear testing question
Testing relatives for a known pathogenic variant can clarify inherited risk. The original report, family context and follow-up plan determine how useful the result becomes.

[…]

A plus sign inside a report icon represents an additional finding beyond the original testing question.
Genetic counselling

Secondary findings in genetic testing: choices, results and follow-up

October 25, 2026 Medical Genetics editorial team Comments Off on Secondary findings in genetic testing: choices, results and follow-up
Understand secondary findings in exome and genome sequencing, with practical consent questions, examples and a clear follow-up checklist.

[…]

A CGG repeat tract with one contrasting AGG interruption illustrates repeat architecture, not a measured repeat size.
Inheritance

FMR1 premutation: repeat results, health and family questions

October 25, 2026 Medical Genetics editorial team Comments Off on FMR1 premutation: repeat results, health and family questions
Read an FMR1 premutation result: CGG repeats, AGG interruptions, personal health and family implications, with practical counselling examples.

[…]

A sequence gap outside a test window illustrates analytical blind spots.
Genomic testing

What a genetic test can miss: understanding a negative result

October 24, 2026 Medical Genetics editorial team Comments Off on What a genetic test can miss: understanding a negative result
Learn why a negative genetic test may leave questions open, with practical examples of test scope, mosaicism, repeat expansions and reanalysis.

[…]

A tumour-cell assay and a clinical evidence marker distinguish an ex-vivo response from a proven patient benefit.
Cancer Genetics

Functional precision oncology: testing cells, then testing clinical value

October 24, 2026 Medical Genetics editorial team Comments Off on Functional precision oncology: testing cells, then testing clinical value
An NCI research agenda highlights living-cell drug testing alongside genomics. A pediatric feasibility study shows why useful laboratory results still require stronger clinical evidence.

[…]

A few highlighted symbols among a larger denominator illustrate why the baseline risk matters. Counts are illustrative, not study data.
Genomic research

Absolute and relative risk: how to interpret genetics headlines

October 23, 2026 Medical Genetics editorial team Comments Off on Absolute and relative risk: how to interpret genetics headlines
Understand absolute and relative risk with worked examples, odds ratios, polygenic scores and a practical worksheet for reading research.

[…]

A highlighted cell expands into a small group, illustrating a blood-cell clone rather than a constitutional germline finding.
Cancer Genetics

Clonal haematopoiesis: when blood DNA can complicate germline testing

October 23, 2026 Medical Genetics editorial team Comments Off on Clonal haematopoiesis: when blood DNA can complicate germline testing
A pathogenic variant detected in blood may be acquired in blood-forming cells. Establishing its origin can change cancer-risk assessment, family testing and specimen selection.

[…]

Posts pagination

« 1 … 10 11 12 13 »

Recent Posts

  • Personalised base editing: what an individual-patient result can show
  • Newborn genome screening: benefits, limits and follow-up
  • 22q11.2 deletion syndrome: one genetic diagnosis, different health needs
  • X-linked hypophosphatemia: connect phosphate loss with PHEX testing
  • TTR T60A (Thr80Ala): what the variant name means

Recent Comments

No comments to show.
Medical Genetics

Clear explanations. Traceable evidence. A thoughtful view of genetics across everyday life, clinical care and research.

Publisher & medical editor: Saeed Reza Ghaffari, MD, MSc, PhD
Medical Genetics Specialist · About the publisher

Learning resourcesTrusted resourcesSource watchAboutEditorial policyPrivacyContact
© 2026 Medical Genetics. Educational information, not individual medical advice. Article review status and sources are shown separately. No affiliation with similarly named journals or professional societies is implied.